aflibercept vs dorzolamide
Side-by-side comparison of aflibercept and dorzolamide Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
Eylea
Trusopt
AHZANTIVE is a medicine used to treat certain eye problems. It helps to stop blood vessels from growing and leaking in the eye.
Dorzolamide eye drops help lower pressure in the eye. It is used for people with ocular hypertension or open-angle glaucoma.
AHZANTIVE treats wet age-related macular degeneration (AMD). It also treats swelling in the macula (the central part of the retina) caused by retinal vein occlusion (RVO) or diabetic macular edema (DME). Additionally, it can treat diabetic retinopathy (DR), an eye disease caused by diabetes.
This medicine treats high pressure inside your eye. It is for people who have ocular hypertension or open-angle glaucoma. Dorzolamide helps to lower the pressure and prevent damage to your optic nerve.
AHZANTIVE is a VEGF inhibitor. VEGF is a protein that promotes the growth of new blood vessels. By blocking VEGF, AHZANTIVE helps to reduce the growth of abnormal blood vessels in the eye and decrease leakage.
Dorzolamide is a type of medicine called a carbonic anhydrase inhibitor. It works by decreasing the amount of fluid your eye makes. This lowers the pressure inside your eye.
- • Bleeding in the eye
- • Eye pain
- • Clouding of the lens of the eye (cataract)
- • Separation of the vitreous gel from the retina
- • Spots in your vision
- • Burning, stinging, or discomfort in the eye right after using the drops
- • Bitter taste in your mouth
- • Superficial punctate keratitis (small spots on the surface of the eye)
- • Signs and symptoms of an allergic reaction in the eye
- Death 7,853
- Trouble seeing 2,013
- Using the medicine for something it's not approved for 1,509
- Loss of sight 1,459
- Eye infection 1,372
- Treatment not working 1,369
- Medicine not effective 704
- Using the medicine for something it's not approved for 475
- Feeling tired 444
- Headache 356
Injections with AHZANTIVE may cause serious eye infections (endophthalmitis), separation of the retina (retinal detachment), and inflammation of blood vessels in the retina. Tell your doctor right away if you have any signs of these problems. AHZANTIVE may also increase the risk of blood clots that can cause stroke or heart attack.
Dorzolamide contains a sulfonamide. Rarely, severe reactions to sulfonamides have happened, even death. If you have signs of a serious reaction or allergy, stop using this medicine right away.
It is not known if AHZANTIVE can harm an unborn baby. AHZANTIVE should be used during pregnancy only if the benefit justifies the risk. It is also not known if AHZANTIVE passes into breast milk.
It is not known if dorzolamide is safe to use during pregnancy. Talk to your doctor if you are pregnant or plan to become pregnant. It is also not known if dorzolamide passes into breast milk.
Also Compare — Nearby Drugs
Compare aflibercept with
Compare dorzolamide with
How to Read This aflibercept vs dorzolamide Comparison
aflibercept is classified in the Anti-VEGF (Ophthalmic Injection) drug class, while dorzolamide sits within the Carbonic Anhydrase Inhibitor (Ophthalmic) class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, aflibercept has 14,206 submissions while dorzolamide has 3,348. Those figures reflect cumulative reporting volume — not per-patient risk — so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between aflibercept and dorzolamide — always consult your physician or pharmacist first.
Important: This comparison is for informational purposes only. Drug effects vary between individuals. Always consult your doctor or pharmacist for personalized medical advice.